Aviva’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.4M | Sell |
96,148
-1,136
| -1% | -$223K | 0.03% | 415 |
|
|
2026
Q1 | $19.1M | Buy |
97,284
+2,427
| +3% | +$472K | 0.03% | 409 |
|
|
2025
Q4 | $16.5M | Buy |
94,857
+1,852
| +2% | +$337K | 0.03% | 440 |
|
|
2025
Q3 | $17.7M | Buy |
93,005
+3,589
| +4% | +$637K | 0.03% | 414 |
|
|
2025
Q2 | $16.1M | Buy |
89,416
+5,562
| +7% | +$966K | 0.03% | 416 |
|
|
2025
Q1 | $14.2M | Buy |
83,854
+12,704
| +18% | +$2.09M | 0.03% | 397 |
|
|
2024
Q4 | $10.7M | Sell |
71,150
-140,165
| -66% | -$21.8M | 0.03% | 431 |
|
|
2024
Q3 | $32.8M | Buy |
211,315
+9,340
| +5% | +$1.39M | 0.09% | 273 |
|
|
2024
Q2 | $27.6M | Buy |
201,975
+46,110
| +30% | +$6.31M | 0.08% | 294 |
|
|
2024
Q1 | $20.7M | Buy |
155,865
+46,371
| +42% | +$6.02M | 0.07% | 326 |
|
|
2023
Q4 | $15.1M | Sell |
109,494
-61,160
| -36% | -$8.04M | 0.05% | 382 |
|
|
2023
Q3 | $20.8M | Sell |
170,654
-4,653
| -3% | -$620K | 0.09% | 297 |
|
|
2023
Q2 | $24.6M | Sell |
175,307
-127,997
| -42% | -$17.6M | 0.1% | 242 |
|
|
2023
Q1 | $42.9M | Buy |
303,304
+114,548
| +61% | +$16.4M | 0.19% | 118 |
|
|
2022
Q4 | $29.5M | Buy |
188,756
+57,972
| +44% | +$8.33M | 0.15% | 172 |
|
|
2022
Q3 | $16M | Buy |
130,784
+17,002
| +15% | +$2.24M | 0.09% | 309 |
|
|
2022
Q2 | $15.1M | Buy |
113,782
+45,714
| +67% | +$6.23M | 0.08% | 343 |
|
|
2022
Q1 | $9.32M | Buy |
68,068
+12,298
| +22% | +$1.71M | 0.05% | 447 |
|
|
2021
Q4 | $9.65M | Buy |
55,770
+7,649
| +16% | +$1.16M | 0.04% | 404 |
|
|
2021
Q3 | $6.99M | Buy |
48,121
+4,500
| +10% | +$658K | 0.03% | 480 |
|
|
2021
Q2 | $5.76M | Sell |
43,621
-1,371
| -3% | -$180K | 0.03% | 551 |
|
|
2021
Q1 | $5.77M | Buy |
44,992
+1,011
| +2% | +$125K | 0.03% | 491 |
|
|
2020
Q4 | $5.24M | Buy |
43,981
+648
| +1% | +$79K | 0.03% | 489 |
|
|
2020
Q3 | $4.96M | Sell |
43,333
-1,030
| -2% | -$122K | 0.03% | 451 |
|
|
2020
Q2 | $5.06M | Sell |
44,363
-46,181
| -51% | -$4.9M | 0.03% | 425 |
|
|
2020
Q1 | $7.27M | Buy |
90,544
+25,590
| +39% | +$2.65M | 0.05% | 322 |
|
|
2019
Q4 | $6.94M | Buy |
64,954
+17,728
| +38% | +$1.85M | 0.04% | 372 |
|
|
2019
Q3 | $5.05M | Sell |
47,226
-2,944
| -6% | -$302K | 0.03% | 420 |
|
|
2019
Q2 | $5.11M | Sell |
50,170
-1,096
| -2% | -$105K | 0.04% | 440 |
|
|
2019
Q1 | $4.61M | Buy |
51,266
+406
| +0.8% | +$35.2K | 0.03% | 481 |
|
|
2018
Q4 | $4.24M | Sell |
50,860
-27,002
| -35% | -$2.53M | 0.03% | 476 |
|
|
2018
Q3 | $8.4M | Sell |
77,862
-2,980
| -4% | -$327K | 0.05% | 372 |
|
|
2018
Q2 | $8.89M | Sell |
80,842
-838
| -1% | -$87.3K | 0.05% | 339 |
|
|
2018
Q1 | $8.19M | Sell |
81,680
-7,370
| -8% | -$755K | 0.05% | 354 |
|
|
2017
Q4 | $8.77M | Sell |
89,050
-10,843
| -11% | -$1.03M | 0.05% | 366 |
|
|
2017
Q3 | $9.35M | Buy |
99,893
+640
| +0.6% | +$67.9K | 0.05% | 365 |
|
|
2017
Q2 | $11M | Buy |
99,253
+460
| +0.5% | +$48.6K | 0.06% | 330 |
|
|
2017
Q1 | $9.7M | Sell |
98,793
-4,904
| -5% | -$467K | 0.06% | 346 |
|
|
2016
Q4 | $9.53M | Buy |
103,697
+4,830
| +5% | +$416K | 0.06% | 346 |
|
|
2016
Q3 | $8.37M | Buy |
98,867
+12,496
| +14% | +$1.05M | 0.05% | 391 |
|
|
2016
Q2 | $7.03M | Sell |
86,371
-72,416
| -46% | -$5.51M | 0.05% | 405 |
|
|
2016
Q1 | $11.3M | Buy |
158,787
+3,119
| +2% | +$209K | 0.08% | 260 |
|
|
2015
Q4 | $11.1M | Buy |
155,668
+84,693
| +119% | +$5.69M | 0.08% | 265 |
|
|
2015
Q3 | $4.36M | Sell |
70,975
-1,886
| -3% | -$132K | 0.04% | 516 |
|
|
2015
Q2 | $5.28M | Sell |
72,861
-5,040
| -6% | -$372K | 0.04% | 487 |
|
|
2015
Q1 | $5.99M | Buy |
77,901
+18,347
| +31% | +$1.31M | 0.04% | 483 |
|
|
2014
Q4 | $3.99M | Sell |
59,554
-110
| -0.2% | -$6.94K | 0.03% | 543 |
|
|
2014
Q3 | $3.62M | Sell |
59,664
-540
| -0.9% | -$33.3K | 0.03% | 585 |
|
|
2014
Q2 | $3.53M | Sell |
60,204
-380
| -0.6% | -$22.3K | 0.03% | 595 |
|
|
2014
Q1 | $3.51M | Sell |
60,584
-60
| -0.1% | -$3.22K | 0.03% | 571 |
|
|
2013
Q4 | $3.25M | Buy |
60,644
+347
| +0.6% | +$20.6K | 0.03% | 585 |
|
|
2013
Q3 | $3.73M | Buy |
60,297
+14,166
| +31% | +$848K | 0.03% | 510 |
|
|
2013
Q2 | $2.8M | Buy |
+46,131
| New | +$2.75M | 0.03% | 508 |
|
Other funds holding DGX
EIG
Aviva's DGX Position: Q2 2026 in Review
Aviva reduced its Quest Diagnostics (DGX) stake by 1.2% in Q2 2026, selling an estimated $223K and leaving 96,148 shares worth $20.4M. The position accounts for 0.03% of the portfolio, ranked #415.
Aviva first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $42.9M in Q1 2023. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Aviva held 96,148 shares of Quest Diagnostics worth $20.4M as of Q2 2026.
- Aviva sold 1,136 Quest Diagnostics shares in Q2 2026, an estimated $223K.
- Quest Diagnostics made up 0.03% of Aviva's portfolio in Q2 2026, its #415 holding.
- Aviva first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
- Aviva's Quest Diagnostics position peaked at $42.9M in Q1 2023.
- 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.